Journal of Antimicrobial Chemotherapy (2001) 48, 291-294
© 2001 The British Society for Antimicrobial Chemotherapy
Brief report |
Genetic and phenotypic characterization of macrolide resistance in group A streptococci isolated from adults with pharyngo-tonsillitis in France
a Laboratoire de Biologie Médicale BIO VSM, 10 rue de la Gare, F-77360 Vaires-sur-Marne; b Laboratoires Abbott, Rungis; c Service de Microbiologie, Centre Hospitalo-Universitaire Robert Debré, Paris; d Service des Maladies Infectieuses, Centre Hospitalo-Universitaire du Bocage, Dijon, France
Three hundred and three strains of group A streptococci (GAS) isolated from adults with pharyngitis were tested to evaluate their phenotype of resistance to macrolideslincosamides and to search for macrolide resistance genes. MICs of clarithromycin were determined. The overall rate of resistance to both erythromycin and clarithromycin was 9.6%. Constitutive, inducible and M phenotypes of resistance were detected in 4.3, 2 and 3.3% of strains, respectively. All constitutive phenotypes harboured ermB genes, whereas inducible phenotypes had the ermTR gene and M phenotypes had the mefA gene. In France, the current resistance rate of GAS to erythromycin and clarithromycin remains low.
Corresponding author. Tel: +33-1-64-72-47-57; Fax: +33-1-64-72-47-58; E-mail: pweber.biovsm{at}wanadoo.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
D. S. Billal, M. Hotomi, J. Shimada, K. Fujihara, K. Ubukata, R. Sugita, and N. Yamanaka Prevalence of Streptococcus Invasive Locus (sil) and Its Relationship with Macrolide Resistance among Group A Streptococcus Strains J. Clin. Microbiol., April 1, 2008; 46(4): 1563 - 1564. [Full Text] [PDF] |
||||
![]() |
A. Rivera, M. Rebollo, E. Miro, M. Mateo, F. Navarro, M. Gurgui, B. Mirelis, and P. Coll Superantigen gene profile, emm type and antibiotic resistance genes among group A streptococcal isolates from Barcelona, Spain. J. Med. Microbiol., August 1, 2006; 55(Pt 8): 1115 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. W. Klaassen and J. W. Mouton Molecular Detection of the Macrolide Efflux Gene: To Discriminate or Not To Discriminate between mef(A) and mef(E) Antimicrob. Agents Chemother., April 1, 2005; 49(4): 1271 - 1278. [Full Text] [PDF] |
||||
![]() |
A. Villedieu, M. L. Diaz-Torres, A. P. Roberts, N. Hunt, R. McNab, D. A. Spratt, M. Wilson, and P. Mullany Genetic Basis of Erythromycin Resistance in Oral Bacteria Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2298 - 2301. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Hasenbein, J. E. Warner, K. G. Lambert, S. E. Cole, A. B. Onderdonk, and A. J. McAdam Detection of Multiple Macrolide- and Lincosamide-Resistant Strains of Streptococcus pyogenes from Patients in the Boston Area J. Clin. Microbiol., April 1, 2004; 42(4): 1559 - 1563. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Garcia-Rey, L. Aguilar, F. Baquero, J. Casal, and J. E. Martin Pharmacoepidemiological Analysis of Provincial Differences between Consumption of Macrolides and Rates of Erythromycin Resistance among Streptococcus pyogenes Isolates in Spain J. Clin. Microbiol., August 1, 2002; 40(8): 2959 - 2963. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Portier, J. Filipecki, P. Weber, G. Goldfarb, D. Lethuaire, and J.-P. Chauvin Five day clarithromycin modified release versus 10 day penicillin V for group A streptococcal pharyngitis: a multi-centre, open-label, randomized study J. Antimicrob. Chemother., February 1, 2002; 49(2): 337 - 344. [Abstract] [Full Text] [PDF] |
||||



